Staging Candidiasis in ICU Patients
NCT01322698
Bacterial Infections and Mycoses, Candidiasis
Nîmes, Gard, France
View Trial DetailsNCT Number: NCT00138502
The purpose of the study is to test the hypothesis that a subpopulation of patients with candiduria are at significant risk for disseminated disease and would benefit from treatment, while others are at low risk from complications and therefore require no antifungal therapy.
Looking for future studies?
Notify MeUp to 99 year
All sexes
Observational
Cedars Sinai Medical Center, Los Angeles, California, United States
This protocol will attempt to generate a detailed clinical profile of patients with funguria and identify subgroups of patients with funguria at high risk for candiduria and determine the relative risks for obtaining candiduria. In addition, it will look at identifying subgroups of patients with funguria at high risk for candidemia and identifying subgroups of patients with funguria at high risk for death. Finally, it will attempt to determine if funguria independently predicts fungemia or death. Data will be complemented by surveillance of a comparable population without funguria.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
National Institute of Allergy and Infectious Diseases (NIAID)
Nih
The Significance of Funguria In Hospitalized Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01322698
Bacterial Infections and Mycoses, Candidiasis
Nîmes, Gard, France
View Trial DetailsNCT02145832
Bacterial Infections and Mycoses, Candidiasis
Antwerp, Rocourt, Liège, Louvain, Namur, Belgium
View Trial DetailsNCT05707156
Aspergillosis, Bacterial Infections and Mycoses
Denver, Colorado, United States
View Trial DetailsNCT05235711
Bacterial Infections and Mycoses, Candidiasis
Rochester, Minnesota, United States
View Trial Details